QSAM Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Net Income	-4.39	-6.07	-12.77	-5.35	-2.3	-0.4	-2.72	-1.5	-3.54	-4.75	Upgrade
Depreciation & Amortization	36,300	0.04	0	1,250	0	0	0.02	0.07	0.08	0.05	Upgrade
Share-Based Compensation	1.25	2.02	9.01	0.28	0	0	0	0.12	0.11	0	Upgrade
Other Operating Activities	-36,299.71	1.31	1.99	-1,245.67	1.32	-0.67	1.49	0.79	1.47	4.45	Upgrade
Operating Cash Flow	-2.85	-2.71	-1.77	-0.74	-0.98	-1.07	-1.21	-0.52	-1.87	-0.25	Upgrade
Capital Expenditures	0	0	0	0	0	0	0	-0	-0.09	-0	Upgrade
Acquisitions	0	0	0	0	0	-0.05	0	0	0	0	Upgrade
Change in Investments	-	-	-	-	-	-0.05	-	-	-	-	Upgrade
Other Investing Activities	-	-	-	-	-	0.05	-	-	-	-0	Upgrade
Investing Cash Flow	0	0	0	0	0	-0.05	0	-0	-0.09	-0	Upgrade
Common Stock Issued	4.01	1.4	2,221,000	100,000	0	0	0	0.16	1.22	0.03	Upgrade
Share Repurchases	0	0	-2,191,462	-64,560	0	0	0	0.42	0	-0	Upgrade
Other Financing Activities	-	0.04	-4,412,458.74	-164,559.25	0.82	0.98	1.5	0.78	0.5	0.22	Upgrade
Financing Cash Flow	4.01	1.44	3.26	0.75	0.82	0.98	1.5	0.52	1.72	0.25	Upgrade
Net Cash Flow	1.16	-1.27	1.49	0.01	-0.16	-0.14	0.3	0	-0.26	-0	Upgrade
Free Cash Flow	-2.85	-2.71	-1.77	-0.74	-0.98	-1.07	-1.21	-0.52	-1.96	-0.25	Upgrade
Free Cash Flow Margin	-	-	-	-	-106.70%	-3205.95%	-1614.73%	-1302.13%	-9789.04%	-	Upgrade
Free Cash Flow Per Share	-0.94	-1.54	-2.23	-5.38	-18.81	-21.43	-25.87	-18.32	-117.39	-158.80	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.